RCE 2.06% 49.5¢ recce pharmaceuticals ltd

Ann: Placement and Entitlement Offer, page-95

  1. 1,439 Posts.
    lightbulb Created with Sketch. 256
    I guess just about anything is potentially doable, but I think it is highly unlikely for this company.

    Why? Well, for one, I believe the management is as weak as anything I've seen on the ASX.

    Secondly, I'm very skeptical of the 'science' behind the product. After all this time, they are absolutely no closer to credibly demonstrating efficacy in humans.

    Then, there is the commercial viability issue, absence from the world's biggest market (USA), etc.

    So, could they overcome all of this in time (and shiploads more money from punters) - maybe. But then, maybe, I'll be able to walk on water one day...
    Last edited by Rykster: 23/09/23
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
49.5¢
Change
0.010(2.06%)
Mkt cap ! $114.6M
Open High Low Value Volume
48.5¢ 51.0¢ 48.5¢ $1.909K 3.908K

Buyers (Bids)

No. Vol. Price($)
4 15775 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 66869 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.